CADENT THERAPEUTICS INC has a total of 63 patent applications. It increased the IP activity by 77.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are COVEX SA, PLIANT THERAPEUTICS INC and AlzeCure Pharma AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 4 | |
#5 | Canada | 3 | |
#6 | Taiwan | 3 | |
#7 | Cuba | 2 | |
#8 | EAPO (Eurasian Patent Organization) | 2 | |
#9 | Hungary | 2 | |
#10 | Israel | 2 | |
#11 | Japan | 2 | |
#12 | Serbia | 2 | |
#13 | Singapore | 2 | |
#14 | Argentina | 1 | |
#15 | Brazil | 1 | |
#16 | Chile | 1 | |
#17 | China | 1 | |
#18 | Colombia | 1 | |
#19 | Jordan | 1 | |
#20 | Republic of Korea | 1 | |
#21 | Mexico | 1 | |
#22 | New Zealand | 1 | |
#23 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Volkmann Robert A | 30 |
#2 | Anderson David R | 29 |
#3 | Keaney Gregg F | 25 |
#4 | Menniti Frank S | 20 |
#5 | Jefson Martin R | 19 |
#6 | Larsen Janus Schreiber | 18 |
#7 | Foster Kelly | 17 |
#8 | Jacobsen Thomas Amos | 17 |
#9 | Amrutkar Dipak Vasantrao | 14 |
#10 | Nielsen Karin Sandager | 14 |
Publication | Filing date | Title |
---|---|---|
WO2020086456A1 | Crystalline forms of potassium channel modulators | |
TW202019932A | Heteroaromatic nmda receptor modulators and uses thereof | |
US2018207138A1 | Methods for the treatment of tremors by positive modulation of sk channels | |
AR110770A1 | POTASSIUM CHANNEL MODULATORS | |
CA3047403A1 | Nmda receptor modulators and uses thereof | |
US2017355708A1 | Potassium channel modulators | |
US2019218200A1 | Potassium channel modulators | |
US2018369245A1 | Thienopyrimidinone NMDA receptor modulators and uses thereof | |
RS60834B1 | Heteroaromatic nmda receptor modulators and uses thereof | |
EP3036221A1 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of nr2b |